Active ingredientAltretamineCat. No. P-A099-001CAS 645-05-6Family · Pharmaceutical analytical standards
Altretamine
An oral anticancer drug derived from melamine, also known as hexamethylmelamine, approved in the United States in 1990 for the palliative treatment of persistent or recurrent ovarian cancer. This family brings together the active ingredient and other impurities.
Did you know?Its mechanism is not fully understood: the body strips the methyl groups from the molecule, releasing formaldehyde and reactive intermediates that are thought to damage tumour cells.
Go to the active ingredient →Active ingredientAltretamineCat. No. P-A099-001CAS 645-05-6
ImpurityAltretamine Dichloro AnalogCat. No. P-A099-002CAS 2401-64-1
ImpurityAltretamine Monochloro AnalogCat. No. P-A099-003CAS 3140-74-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.